Top Markets
Coin of the day
CSL Limited CSL Limited

CSL Limited

CSL
Pozycja w akcjach #432
CSL Limited researches, develops, manufactures, markets, and distributes... CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.
Cena akcji
$99.32
Kapitalizacja rynkowa
$48.20B
Zmiana (1 dzień)
0.98%
Zmiana (1 rok)
-32.14%
Kraj
AU
Handel CSL Limited (CSL)

Kategoria

Zyski dla CSL Limited (CSL)
Zyski w Dec 2025 TTM: $1.61B
Według najnowszych raportów finansowych CSL Limited, obecny zysk firmy wynosi $1.61B. W roku 2024 firma osiągnęła zysk w wysokości $3.38B, wzrost w porównaniu do zysku z roku 2023, który wynosił $2.66B. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy CSL Limited od 2000 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
2026 (TTM) $1.61B -56.65%
2025 $3.72B 10.34%
2024 $3.38B 26.74%
2023 $2.66B -4.19%
2022 $2.78B -6.80%
2021 $2.98B 15.92%
2020 $2.57B 9.89%
2019 $2.34B 2.63%
2018 $2.28B 35.00%
2017 $1.69B 8.61%
2016 $1.56B -9.22%
2015 $1.71B 6.84%
2014 $1.60B 19.64%
2013 $1.34B 5.36%
2012 $1.27B -7.31%
2011 $1.37B 38.29%
2010 $992.87M 11.00%
2009 $894.45M 2.37%
2008 $873.74M 56.73%
2007 $557.47M 493.43%
2006 $93.94M -74.77%
2005 $372.39M 201.20%
2004 $123.64M 168.99%
2003 $45.96M -7.38%
2002 $49.63M -8.38%
2001 $54.17M 88.04%
2000 $28.81M 0.00%
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
$20.51B 1,170.24%
DK
$4.64B 187.63%
US
$5.23B 224.03%
US
$2.14B 32.42%
BE
$1.45B -10.11%
NL